Raymond James Financial’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$247K Buy
10,382
+1,063
+11% +$28.9K ﹤0.01% 4767
2025
Q4
$272K Buy
9,319
+761
+9% +$23.7K ﹤0.01% 4640
2025
Q3
$274K Buy
8,558
+886
+12% +$28K ﹤0.01% 4461
2025
Q2
$251K Sell
7,672
-7,544
-50% -$228K ﹤0.01% 4399
2025
Q1
$431K Buy
15,216
+8,109
+114% +$255K ﹤0.01% 4020
2024
Q4
$210K Buy
+7,107
New +$211K ﹤0.01% 4382

Other funds holding HEAL

Raymond James Financial's HEAL Position: Q1 2026 in Review

Raymond James Financial increased its Global X Funds Global X HealthTech ETF (HEAL) stake by 11% in Q1 2026, buying an estimated $28.9K and bringing the position to 10,382 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #4767.

Raymond James Financial first reported a position in HEAL in Q4 2024 and has held it in 6 quarters since. The position peaked at $431K in Q1 2025. 30 funds tracked by Wall St. Rank hold HEAL as of Q1 2026.

  • Raymond James Financial held 10,382 shares of Global X Funds Global X HealthTech ETF worth $247K as of Q1 2026.
  • Raymond James Financial bought 1,063 Global X Funds Global X HealthTech ETF shares in Q1 2026, an estimated $28.9K.
  • Global X Funds Global X HealthTech ETF made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4767 holding.
  • Raymond James Financial first reported a position in Global X Funds Global X HealthTech ETF in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Global X Funds Global X HealthTech ETF position peaked at $431K in Q1 2025.
  • 30 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.